Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 6, 1997, Pages 1301-1306

  Chang, Jen Chyi ^a   Hsueh, Po Ren ^b   Wu, Jiunn Jong ^a   Ho, Shen Wu ^b,c   Hsieh, Wei Chuan ^b   Luh, Kwen Tay ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; CEFALOTIN; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; ERYTHROMYCIN; GLYCOPEPTIDE; IMIPENEM; LATAMOXEF; MINOCYCLINE; OFLOXACIN; PIPERACILLIN;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CHRYSEOBACTERIUM MENINGOSEPTICUM; FLAVOBACTERIUM; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; TAIWAN;

EID: 0030976199     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.6.1301     Document Type: Article

References (35)

1. Aber, R. C., C. Wennersten, and R. C. Moellering, Jr. 1978. Antimicrobial susceptibility of flavobacteria. Antimicrob. Agents Chemother. 14:483-487.
2. Altmann, G., and B. Bogokovsky. 1971. In vitro sensitivity of Flavobacterium meningosepticum to antimicrobial agents. J. Med. Microbiol. 4:296-299.
3. Bradford, P. A., and C. C. Sanders. 1992. Use of predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbctam. Antimicrob. Agents Chemother. 36:394-400.
4. Bruun, B. 1987. Antimicrobial susceptibility of Flavobacterium meningosepticum strains identified by DNA-DNA hybridization. Acta Pathol. Microbiol. Immunol. Scand. Sect. B. 95:95-101.
5. Bucci, F. A., Jr., and E. J. Holland. 1991. Flavobacterium meningosepticum keratitis successfully treated with topical trimethoprim-sulfamethoxazole. Am. J. Ophthalmol. 111:116-118.
6. Fass, R. J., and J. Barnishan. 1980. In vitro susceptibilities of non-fermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Rev. Infect. Dis. 2:841-853.
7. George, R. M., C. P. Cochran, and W. E. Wheeler. 1961. Epidemic meningitis of the newborn caused by flavobacteria. II. Clinical manifestations and treatment. Am. J. Dis. Child. 101:296-304.
8. Hawley, H. B., and D. W. Gump. 1973. Vancomycin therapy of bacterial meningitis. Am. J. Dis. Child. 126:261-264.
9. Hsueh, P. R., H. M. Chen, A. Y. Huang, and J. J. Wu. 1995. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob. Agents Chemother. 39:2239-2242.
10. Hsueh, P. R., J. J. Wu, T. R. Hsiue, and W. C. Hsieh. 1995. Bacteremic necrotizing fasciitis due to Flavobacterium odoratum. Clin. Infect. Dis. 21: 1337-1338.
11. Hsueh, P. R., T. R. Hsiue, and W. C. Hsieh. 1996. Pyomyositis in intravenous drug abusers: report of a unique case and review of the literature. Clin. Infect. Dis. 22:858-860.
12. Hsueh, P. R., L. J. Teng, S. W. Ho, W. C. Hsieh, and K. T. Luh. 1996. Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices. J. Clin. Microbiol. 34:1908-1913.
13. Hsueh, P. R., T. R. Hsiue, J. J. Wu, L. J. Teng, S. W. Ho, W. C. Hsieh, and K. T. Luh. 1996. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin. Infect. Dis. 23:550-555.
14. Husson, M. O., D. Izard, L. Bouillet, and H. Lecherc. 1985. Comparative in-vitro activity of ciprofloxacin against non-fermenters. J. Antimicrob. Chemother. 15:457-462.
15. Jorgensen, J. H., L. A. Maher, and A. W. Howell. 1991. Activity of meropenem against antibiotic-resistant or infrequently encountered gram-negative bacilli. Antimicrob. Agents Chemother. 35:2410-2414.
16. Lee, E. L., M. J. Robinson, M. L. Thong, and S. D. Puthucheary. 1976. Rifamycin in neonatal flavobacteria meningitis. Arch. Dis. Child. 51:209-213.
17. Maderazo, E. G., H. P. Bassaris, and R. Quintilliani. 1974. Flavobacterium meningosepticum meningitis in a newborn infant. J. Pediatr. 85:675-676.
18. Metzler, C. M., and R. M. DeHaan. 1974. Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. J. Infect. Dis. 130:588-594.
19. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
20. National Committee for Clinical Laboratory Standards. 1993. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
21. Plotkin, S. A., and J. C. McKitrick. 1966. Nosocomial meningitis of the newborn caused by a Flavobacterium. JAMA 198:194-196.
22. Ratner, H. 1984. Flavobacterium meningosepticum. Infect. Control 5:237-239.
23. Scully, B. E., and H. C. Neu. 1986. Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa. J. Antimicrob. Chemother. 18(Suppl. D):179-185.
24. Sheridan, R. I., C. M. Ryan, M. S. Pasternack, J. M. Weber, and R. G. Tompkins. 1993. Flavobacterial sepsis in massively burned pediatric patients. Clin. Infect. Dis. 17:185-187.
25. Siegman-Igra, Y., D. Schwartz, G. Soferman, and N. Konforti. 1987. Flavobacterium group IIb bacteremia: report of a case and review of Flavobacterium infections. Med. Microbiol. Immunol. 176:103-111.
26. Stamm, W. E., J. J. Colella, R. L. Anderson, and R. E. Dixon. 1975. Indwelling arterial catheters as a source of nosocomial bacteremia - an outbreak caused by Flavobacterium species. N. Engl. J. Med. 292:1099-1102.
27. Strandberg, D. A., J. H. Jorgensen, and D. J. Drutz. 1983. Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli. Antimicrob. Agents Chemother. 24:282-286.
28. Sundin, D., B. D. Gold, F. E. Berkowitz, D. A. Sehwartz, and D. Goo. 1991. Community-acquired Flavobacterium meningosepticum meningitis, pneumonia and septicemia in a normal infant. Pediatr. Infect. Dis. J. 10:73-76.
29. Tam, A. Y. C., R. W. H. Yung, and K. Fu. 1989. Fatal pneumonia caused by Flavobacterium meningosepticum. Pediatr. Infect. Dis. J. 8:252-254.
30. Thong, M. L., S. D. Puthucheary, and E. L. Lee. 1981. Flavobacterium meningosepticum infection: an epidemiologic study in a newborn nursery. J. Clin. Pathol. 34:429-433.
31. Uchihara, T., T. Yokota, S. Watabiki, M. Ueki, and S. Miyake. 1988. Flavobacterium meningosepticum meningitis in an adult. Am. J. Med. 85:738-739.
32. von Graevenitz, A. 1995. Nonfermentative gram-negative bacteria, p. 520-532. In P. R. Murray, E. J. Barron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
33. von Graevenitz, A., and M. Grehn. 1977. Susceptibility studies of Flavobacterium II-b. FEMS Microbiol. Lett. 2:289-292.
34. Werthamer, S., and M. Weiner. 1972. Subacute bacterial endocarditis due to Flavobacterium meningosepticum. Am. J. Clin. Pathol. 57:410-412.
35. Yabunchi, E., T. Ito, E. Tanimura, N. Yamamoto, and A. Ohyama. 1981. In vitro antimicrobial activity of ceftizoxime against glucose nonfermentative gram-negative rods. Antimicrob. Agents Chemother. 20:136-139.